Table 3.
Combined predictive model of developing a first anxiety disorder (AD) after cancer diagnosis
| Comparison | Predictor | β | SE β | Odds Ratio Exp(β) |
|---|---|---|---|---|
| No AD vs.Post-Cancer AD | Age | −.01 | .03 | .99 |
| Side effects during cancer treatment | .03 | .11 | 1.03 | |
| Current side effects from treatment | −.42** | .14 | .66 | |
| Reported cancer stage | −.43 | .29 | .65 | |
| Received radiation | −.54 | .60 | .65 | |
| Previous depression episode | .43 | .56 | 1.53 | |
| First AD onset Pre-Cancer vs. Post-Cancer | Age | −.02 | .03 | .98 |
| Number of side effects during cancer treatment | .00 | .11 | .98 | |
| Number of current side effects from treatment | −.19 | .13 | .83 | |
| Reported cancer stage | −.76* | .30 | .47 | |
| Received radiation | −1.16a | .60 | .31 | |
| Previous depression episode | .91 | .57 | 2.48 | |
| No AD vs.Post-Cancer AD | Model Intercept | 4.49* | 1.96 | |
| Pre-Cancer vs. Post-Cancer AD | Model Intercept | 5.55** | 1.99 | |
| Overall model fit: −2 Log Likelihood χ2=37.03***, df=12 Cox and Snell R2=.26, Nagelkerke=.30 | ||||
a
p=.05;
*
p<.05
**
p<.01
***
p<.001
Post-Cancer AD=reference category (coded 2)